NORTHSTAR, NCT03410043: Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, Study |
|
|
| Active, not recruiting | 2 | 173 | US | Osimertinib, AZD-9291, AZD9291, Mereletinib, Tagrisso, Radiation Therapy, Cancer Radiotherapy, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Therapeutic Conventional Surgery | M.D. Anderson Cancer Center, National Cancer Institute (NCI), National Comprehensive Cancer Network | Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8 | 06/25 | 06/25 | | |
